By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cartagenia has opened its first North American office in Boston, the Leuven, Belgium-based bioinformatics firm said today.

The opening of the new office follows recently signed contracts with GeneDx and the Los Angeles Children's Hospital.

The firm also said that it has named Drew Arnold, VP of sales and business development for North America, to head the office. He joins Cartagenia from GenomeQuest, where he headed the global sales team.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

Jun
23
Sponsored by
PerkinElmer

This webinar will demonstrate how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.